Ldl-c Levels In Secondary Prevention: The Lower The Better and The Sooner The Better

R. Vázquez
{"title":"Ldl-c Levels In Secondary Prevention: The Lower The Better and The Sooner The Better","authors":"R. Vázquez","doi":"10.19080/jocct.2021.17.555954","DOIUrl":null,"url":null,"abstract":"Ischemic heart disease continues to be the leading cause of death worldwide. Low-density lipoproteins cholesterol (LDL-c) is the main responsible factor in its pathophysiology. Despite the great farmacological advance in lipid-lowering treatments (estatins, ezetimibe, PCSK9 inhibitors and those that remain to come bempedoic acid and inclisiran) most of our patients in secondary prevention present LDL-c levels over the recommended by the Clinical Practice Guidelines. For this reason, we developed a specific program in an attempt to achieve the goal of lowering LDL-c the lower and the sooner the better.","PeriodicalId":73635,"journal":{"name":"Journal of cardiology & cardiovascular therapy","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cardiology & cardiovascular therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19080/jocct.2021.17.555954","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Ischemic heart disease continues to be the leading cause of death worldwide. Low-density lipoproteins cholesterol (LDL-c) is the main responsible factor in its pathophysiology. Despite the great farmacological advance in lipid-lowering treatments (estatins, ezetimibe, PCSK9 inhibitors and those that remain to come bempedoic acid and inclisiran) most of our patients in secondary prevention present LDL-c levels over the recommended by the Clinical Practice Guidelines. For this reason, we developed a specific program in an attempt to achieve the goal of lowering LDL-c the lower and the sooner the better.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
二级预防中的Ldl-c水平:越低越好,越早越好
缺血性心脏病仍然是全球死亡的主要原因。低密度脂蛋白胆固醇(LDL-c)是其病理生理学的主要原因。尽管在降脂治疗方面取得了巨大的临床进展(依折麦布、PCSK9抑制剂以及那些即将出现的贝米多酸和inclisiran),但我们在二级预防中的大多数患者的LDL-c水平都超过了《临床实践指南》的建议。为此,我们开发了一个特定的程序,试图实现LDL-c越低、越快越好的目标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Role of Cardiovascular Magnetic Resonance Imaging in Early Detection of Myocarditis in Patients Recovered from COVID-19 Ldl-c Levels In Secondary Prevention: The Lower The Better and The Sooner The Better Mechanical Pulmonary Valve Thrombosis: Recurrence and Response to Thrombolytic Therapy Ocular Ischemic Syndrome as a Clue for Carotid Artery Stenosis The results of Percutaneous Transcatheter Pulmonary valvuloplasty in Adult Patients
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1